Abstract

We have previously established that epigenetic regulator RING1 and YY1 binding protein (RYBP) is required for the contractility of embryonic stem (ES) cell derived cardiomyocytes (CMCs), suggesting its essential role in contractility. In order to investigate the underlying molecular events of this phenotype, we compared the transcriptomic profile of the wild type and Rybp null mutant ES cells and CMCs differentiated from these cell lines. We identified genes related to ion homeostasis, cell adhesion and sarcomeric organization affected in the Rybp null mutant CMCs, by using hierarchical gene clustering and Gene Ontology analysis. We have also demonstrated that the amount of RYBP is drastically reduced in the terminally differentiated wild type CMCs whilst it is broadly expressed in the early phase of differentiation when progenitors form. We also describe that RYBP is important for the proper expression of key cardiac transcription factors including Mesp1, Shh and Mef2c. These findings identify Rybp as a gene important for both early cardiac gene transcription and consequent sarcomere formation necessary for contractility. Since impairment of sarcomeric function and contractility plays a central role in reduced cardiac pump function leading to heart failures in human, current results might be relevant to the pathophysiology of cardiomyopathies.

Highlights

  • Contractile disorders, such as cardiomyopathy and arrhythmia are often derived from structural malformations of the developing heart and lead to congenital heart defects (CHDs) [1]

  • Since contractility depends on the presence of CMCs, first we determined whether RING1 and YY1 binding protein (RYBP) is present in CMCs

  • Wild type embryonic stem (ES) cells were differentiated for 21 days and fixed in 4% PFA at d7, d14 and d21 where d7 represents the early and d14, d21 represent the terminal stages of cardiac differentiation (Fig 1)

Read more

Summary

Introduction

Contractile disorders, such as cardiomyopathy and arrhythmia are often derived from structural malformations of the developing heart and lead to congenital heart defects (CHDs) [1]. Mutations in key cardiac transcription factors such as NK2 Homeobox 5 (Nkx2-5), Myocyte Enhancer factor 2C (Mef2c) and T-box 5 (Tbx5) cause serious problems in heart development and contractile functions [1,2]. The major effectors and regulators of cardiac transcription are identified, there are only limited information available about how improper gene expression and structural disorganization result in heart development defects [3,4,5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call